Drug Shortage Report for HYPERTET S/D

Last updated on 2021-05-12 History
Report ID 139131
Drug Identification Number 02230697
Brand name HYPERTET S/D
Common or Proper name TETANUS IMMUNOGLOBULIN (HUMAN), SOLVENT DETERGENT TREATED
Company Name GRIFOLS THERAPEUTICS LLC
Market Status DORMANT
Active Ingredient(s) TETANUS IMMUNOGLOBULIN
Strength(s) 250UNIT
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 250 IU Syringe
ATC code J06BB
ATC description IMMUNOGLOBULINS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-05-11
Actual start date
Estimated end date 2021-05-12
Actual end date 2021-05-11
Shortage status Resolved
Updated date 2021-05-12
Company comments To ensure continuous supply while Grifols implements a planned manufacturing process update for this product, Grifols has received authorization from Health Canada to distribute HyperTET® S/D Lot No. T2MDE00023 that has a US label on its pre-filled syringe.
Health Canada comments
Tier 3 Status No
Company contact information GrifolsCanadaMedInfo@grifols.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2021-05-12 English Compare
v13 2021-05-11 French Compare
v12 2021-05-11 English Compare
v11 2021-05-11 English Compare
v10 2021-05-10 French Compare
v9 2021-05-10 French Compare
v8 2021-05-10 English Compare
v7 2021-05-10 French Compare
v6 2021-05-10 English Compare
v5 2021-05-10 French Compare
v4 2021-05-10 French Compare
v3 2021-05-10 English Compare
v2 2021-05-10 English Compare
v1 2021-05-10 English Compare

Showing 1 to 14 of 14